The Cooper Companies, Inc.
COO
Key stats
- Open
- 63.26
- Day high
- 63.50
- Day low
- 62.11
- Previous close
- 62.93
- Volume
- 1.95M
- VWAP
- 62.37
- 52-week high
- 89.83
- 52-week low
- 51.01
- Market cap
- 11.97B
- Shares out
- 190.16M
- Employees
- 15,000
- Listed
- 1983
About The Cooper Companies, Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
OPHTHALMIC GOODS · SAN RAMON, CA · coopercos.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 4.1K
- Put open interest
- 1.0K
- Put/call
- 0.25
- At-the-money IV
- 38.1%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 65 put | 2.38 | Nov 9, 1:42 PM | 19 | 22 | — |
| 75 put | 20.54 | Sep 10, 11:52 AM | 10 | 0 | — |
| 70 put | 4.00 | Aug 31, 9:34 AM | 6 | 0 | — |
| 55 call | 9.40 | Nov 4, 2:42 PM | 5 | 155 | 65.0% |
| 65 call | 0.95 | Nov 10, 12:11 PM | 5 | 1.6K | 33.2% |
| 60 put | 0.45 | Nov 11, 9:42 AM | 5 | 40 | 48.3% |
Quarterly results
Massive · Sep 9, 2026| Q3 2026 to Jul 31, 2026 | Q2 2026 to Apr 30, 2026 | Q1 2026 to Jan 31, 2026 | Q4 2025 to Oct 31, 2025 | |
|---|---|---|---|---|
| Revenue | $1.07B | $1.08B | $1.02B | $1.07B |
| Gross profit | $711.90M | $735.40M | $695.20M | $650.80M |
| Operating income | $222.00M | −$31.00M | $212.80M | $140.40M |
| Net income | $432.80M | −$77.90M | $130.80M | $84.60M |
| Diluted EPS | 2.24 | -0.40 | 0.66 | 0.43 |
| Operating cash flow | $341.70M | $182.80M | $260.90M | $247.90M |
| Assets | $12.67B | $12.48B | $12.42B | $12.39B |
| Liabilities | $4.34B | $4.24B | $4.06B | $4.16B |
| Equity | $8.33B | $8.24B | $8.36B | $8.24B |
Technicals
Massive · Nov 12, 2026- 50-day average58.65
- 200-day average68.05
- RSI (14 days)54.9
Short interest
Massive · Oct 30, 2026- Oct 30, 202610.11M shares · 3.4 days to cover
- Oct 15, 20269.09M shares · 2.4 days to cover
- Sep 30, 20268.33M shares · 1.6 days to cover
- Sep 15, 202610.01M shares · 1.9 days to cover
Dividends
Massive · Jul 26, 2023- Ex Jul 26, 2023, paid Aug 11, 20230.0300 · 2 a year
- Ex Jan 20, 2023, paid Feb 10, 20230.0300 · 2 a year
- Ex Jul 26, 2022, paid Aug 11, 20220.0300 · 2 a year
- Ex Jan 20, 2022, paid Feb 9, 20220.0300 · 2 a year
- Ex Jul 26, 2021, paid Aug 11, 20210.0300 · 2 a year
- Ex Jan 21, 2021, paid Feb 9, 20210.0300 · 2 a year
- Ex Jul 22, 2020, paid Aug 7, 20200.0300 · 2 a year
- Ex Jan 22, 2020, paid Feb 10, 20200.0300 · 2 a year
Splits
Massive · Feb 20, 2024- Feb 20, 20244-for-1
Related companies
MassiveNews coverage
No stories about The Cooper Companies, Inc. right now.